Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 3

Sponsor Class

OTHER 26NIH 7INDUSTRY 5NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Lymphoma 42Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Leukemia 14Lymphoma, Large B-Cell, Diffuse 13Prostatic Neoplasms 11Lymphoma, Follicular 11Hodgkin Disease 11Burkitt Lymphoma 11Multiple Myeloma 7Lymphoma, Large-Cell, Anaplastic 5Leukemia, Biphenotypic, Acute 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasms, Plasma Cell 4Dendritic Cell Sarcoma, Interdigitating 4Waldenstrom Macroglobulinemia 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Leukemia, Lymphocytic, Chronic, B-Cell 3Lymphoma, Non-Hodgkin 2Lymphoma, B-Cell, Marginal Zone 2Immunoblastic Lymphadenopathy 2Cardiotoxicity 2Thymoma 1Thrombocytopenia 1Sezary Syndrome 1Recurrence 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Plasmablastic Lymphoma 1Pain 1Neutropenia 1

Interventions

Rituximab 8Vincristine 5Doxorubicin 5Cyclophosphamide 5Methotrexate 4Cytarabine 4Bortezomib 4Radiotherapy 3Prednisone 3Bendamustine Hydrochloride 3Peripheral Blood Stem Cell Transplantation 2Melphalan 2Leucovorin 2Dexamethasone 2CT-P10 2zanubrutinib 1obinutuzumab 1merphos 1liposomal amphotericin B 1ixabepilone 1ibritumomab tiuxetan 1fludarabine phosphate 1carmustine, poliferprosan 20 drug combination 1alvocidib 1acalabrutinib 1Whole-Body Irradiation 1Watchful Waiting 1Vancomycin 1Tazobactam 1Tacrolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Lymphoma, Mantle-Cell × Prednisone × Clear all
NCT00070018 2022-01-11

S0313 Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma

SWOG Cancer Research Network

Phase 2 Completed
46 enrolled 5 charts
Lymphoid

Burkitt Lymphoma, Lymphoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Mantle-Cell

NCT00376961 2017-11-06

S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

SWOG Cancer Research Network

Phase 2 Completed
68 enrolled 9 charts
Lymphoid

Lymphoma, Lymphoma, Mantle-Cell

NCT00005089 2017-01-16

S0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma

SWOG Cancer Research Network

Phase 2 Completed
71 enrolled
Lymphoid

Burkitt Lymphoma, Lymphoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡